Leerink Partners Starts Neurogene (NGNE) at Outperform
Tweet
Share
E-mailGet Alerts NGNE Hot Sheet
Price: $36.14 +1.43%
Rating Summary:
9 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
9 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Leerink Partners analyst Mani Foroohar initiates coverage on Neurogene (NASDAQ: NGNE) with a Outperform rating and a price target of $46.00.
For an analyst ratings summary and ratings history on Neurogene click here. For more ratings news on Neurogene click here.
Shares of Neurogene closed at $29.96 yesterday.
You May Also Be Interested In
- Neurogene (NGNE) PT Lowered to $65 at H.C. Wainwright
- UBS Starts Schrodinger (SDGR) at Neutral
- Neurogene (NGNE) PT Lowered to $166 at Canaccord
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
